Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nano Pajhoohan Pardis is a specialized nanotechnology company based in Iran that focuses on the development and commercialization of nanofiber-based medical and industrial products. The company utilizes advanced electrospinning platforms to manufacture high-performance respiratory masks, such as the Nano-Pak series, and innovative wound dressings designed for accelerated tissue regeneration. Beyond personal protective equipment, the firm is actively involved in the research and development of nanofiber-based drug delivery systems and scaffolds for tissue engineering. Nano Pajhoohan Pardis operates within the Pardis Technology Park ecosystem and maintains strong ties with academic research centers to translate nanomaterial science into clinical applications. Their products are primarily aimed at improving infection control and enhancing therapeutic outcomes in wound management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nano Pajhoohan Pardis.